department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Liquidia Corp ($LQDA) · pharmadog

PUBLIC COMPANY

$LQDALiquidia Corp

Morrisville, NC, USupdated 2h ago

SEC EDGAR ↗Yahoo Finance ↗

community read0 votes

pipeline

1

marketed

0

phase 3

1

catalysts ytd

1

approvals ytd

0

recalls ytd

0

Pipeline(1)

pipeline depth1 products

1Phase 3

treprostinil SR

Pulmonary Arterial Hypertension

Prostacyclin receptor

Upcoming

no upcoming catalysts on record

Recent(90d)

earnings (1)

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Liquidia Corp jobs →

News

no news has mentioned this company yet

identifiers

ticker

$LQDA

SEC CIK

0001819576

country

US

source

sec_tickers

mentioned in

0news items

entity-linker matched

Liquidia Corp earnings

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

$LQDA80.16+1.55%

Data sources

last refreshed 5m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Insider activity

source: SEC Form 4

90d open-market buys

$0

0 transactions

90d open-market sells

$20.74M

21 transactions

net (buys − sells)

−$20.74M

non-derivative only

open-market buys + sells

Apr 17, 26SELLJEFFS ROGER· Chief Executive Officer18,839 sh @ $40.60−$765K↗
Apr 16, 26SELLJEFFS ROGER· Chief Executive Officer25,000 sh @ $40.31−$1.01M↗
Apr 15, 26SELLKaseta Michael· CFO and COO86,971 sh @ $40.14−$3.49M↗
Apr 15, 26SELLKaseta Michael· CFO and COO43,375 sh @ $40.14−$1.74M↗
Apr 15, 26SELLJEFFS ROGER· Chief Executive Officer25,000 sh @ $40.14−$1.00M↗
Apr 15, 26SELLKaseta Michael· CFO and COO9,044 sh @ $40.14−$363K↗
Apr 14, 26SELLJEFFS ROGER· Chief Executive Officer3,300 sh @ $40.00−$132K↗
Apr 14, 26SELLKaseta Michael· CFO and COO3,000 sh @ $40.00−$120K↗
Apr 13, 26SELLJEFFS ROGER· Chief Executive Officer32,744 sh @ $38.37−$1.26M↗
Apr 13, 26SELLKaseta Michael· CFO and COO18,958 sh @ $38.37−$727K↗
Apr 13, 26SELLSchundler Russell· General Counsel13,692 sh @ $38.37−$525K↗
Apr 13, 26SELLSaggar Rajeev· Chief Medical Officer9,220 sh @ $38.37−$354K↗
Apr 13, 26SELLMoomaw Scott· Chief Commercial Officer8,861 sh @ $38.37−$340K↗
Apr 13, 26SELLAdair Jason· Chief Business Officer7,301 sh @ $38.37−$280K↗
Apr 13, 26SELLBoyle Dana· Chief Accounting Officer5,101 sh @ $38.37−$196K↗
Apr 13, 26SELLKrepp Sarah· Chief Human Resource Officer4,557 sh @ $38.37−$175K↗
Apr 13, 26SELLMoomaw Scott· Chief Commercial Officer1,686 sh @ $38.20−$64K↗
Apr 10, 26SELLKaseta Michael· CFO and COO23,821 sh @ $40.14−$956K↗
Apr 10, 26SELLJEFFS ROGER· Chief Executive Officer21,433 sh @ $40.12−$860K↗
Apr 9, 26SELLKaseta Michael· CFO and COO133,789 sh @ $40.24−$5.38M↗

$LQDA80.16+1.55%